Isbn: 9781493900916 - new drug development: an introduction to clinical trials: second edition (7 resultados)

ISBN
Refinar con la Búsqueda avanzada

Filtrar la búsqueda

  • Libros (7)

  • Nuevo (7)

a

Intervalo de precios personalizado (EUR)

a

    • Idioma: Inglés

      Editorial: Springer, 2014

      1493900919 / 9781493900916

      • Tapa blanda

      Librería: Ria Christie Collections, Uxbridge, Reino UnidoRia Christie Collections

      Vendedor de 5 estrellas
      Contactar con el vendedor

      Condición: Nuevo

      EUR 276,43

      Envío por EUR 13,17 
      Se envía de Reino Unido a Estados Unidos de America

      Cantidad disponible: Más de 20 disponibles

      Condición: New. In English.

    • Más imágenes

      Idioma: Inglés

      Editorial: Springer, 2014

      1493900919 / 9781493900916

      • Tapa blanda

      Librería: preigu, Osnabrück, Alemaniapreigu

      Vendedor de 5 estrellas
      Contactar con el vendedor

      Condición: Nuevo

      EUR 301,55

      Envío por EUR 70,00 
      Se envía de Alemania a Estados Unidos de America

      Cantidad disponible: 5 disponibles

      Taschenbuch. Condición: Neu. New Drug Development | An Introduction to Clinical Trials: Second Edition | J. Rick Turner | Taschenbuch | xxv | Englisch | 2014 | Springer | EAN 9781493900916 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.

    • Idioma: Inglés

      Editorial: Springer, 2014

      1493900919 / 9781493900916

      • Tapa blanda

      Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH

      Vendedor de 5 estrellas
      Contactar con el vendedor

      Condición: Nuevo

      EUR 485,77

      Envío por EUR 30,50 
      Se envía de Alemania a Estados Unidos de America

      Cantidad disponible: 1 disponibles

      Taschenbuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - New Drug Development: Second Edition provides an overview of the design concepts and statistical practices involved in therapeutic drug development. This wide spectrum of activities begins with identifying a potentially useful drug candidate that can perhaps be used in the treatment or prevention of a condition of clinical concern, and ends with marketing approval being granted by one or more regulatory agencies. In between, it includes drug molecule optimization, nonclinical and clinical evaluations of the drug's safety and efficacy profiles, and manufacturing considerations. The more inclusive term lifecycle drug development can be used to encompass the postmarketing surveillance that is conducted all the time that a drug is on the market and being prescribed to patients with the relevant clinical condition. Information gathered during this time can be used to modify the drug (for example, dose prescribed, formulation, and mode of administration) in terms of its safety and its effectiveness. The central focus of the first edition of this book is captured by its subtitle, 'Design, Methodology, and Analysis'. Optimum quality study design and experimental research methodology must be employed if the data collected-numerical representations of biological information-are to be of optimum quality. Optimum quality data facilitate optimum quality statistical analysis and interpretation of the results obtained, which in turn permit optimum quality decisions to be made: Rational decision making is predicated on appropriate research questions and optimum quality numerical information. The book took a non-computational approach to statistics, presenting instead a conceptual framework and providing readers with a sound working knowledge of the importance of design, methodology, and analysis. Not everyone needs to be an expert in statistical analysis, but it is very helpful for work (or aspire to work) in the pharmaceutical and biologics industries to be aware of the fundamental importance of a sound scientific and clinical approach to the planning, conduct, and analysis of clinical trials.

    • Idioma: Inglés

      Editorial: Springer New York Okt 2014, 2014

      1493900919 / 9781493900916

      • Tapa blanda
      • Impresión bajo demanda

      Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, AlemaniaBuchWeltWeit Ludwig Meier e.K.

      Vendedor de 5 estrellas
      Contactar con el vendedor

      Condición: Nuevo

      EUR 203,29

      Envío por EUR 23,00 
      Se envía de Alemania a Estados Unidos de America

      Cantidad disponible: 2 disponibles

      Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -New Drug Development: Second Edition provides an overview of the design concepts and statistical practices involved in therapeutic drug development. This wide spectrum of activities begins with identifying a potentially useful drug candidate that can perhaps be used in the treatment or prevention of a condition of clinical concern, and ends with marketing approval being granted by one or more regulatory agencies. In between, it includes drug molecule optimization, nonclinical and clinical evaluations of the drug's safety and efficacy profiles, and manufacturing considerations. The more inclusive term lifecycle drug development can be used to encompass the postmarketing surveillance that is conducted all the time that a drug is on the market and being prescribed to patients with the relevant clinical condition. Information gathered during this time can be used to modify the drug (for example, dose prescribed, formulation, and mode of administration) in terms of its safety and its effectiveness. The central focus of the first edition of this book is captured by its subtitle, 'Design, Methodology, and Analysis'. Optimum quality study design and experimental research methodology must be employed if the data collected-numerical representations of biological information-are to be of optimum quality. Optimum quality data facilitate optimum quality statistical analysis and interpretation of the results obtained, which in turn permit optimum quality decisions to be made: Rational decision making is predicated on appropriate research questions and optimum quality numerical information. The book took a non-computational approach to statistics, presenting instead a conceptual framework and providing readers with a sound working knowledge of the importance of design, methodology, and analysis. Not everyone needs to be an expert in statistical analysis, but it is very helpful for work (or aspire to work) in the pharmaceutical and biologics industries to be aware of the fundamental importance of a sound scientific and clinical approach to the planning, conduct, and analysis of clinical trials. 284 pp. Englisch.

    • Idioma: Inglés

      Editorial: Springer, 2014

      1493900919 / 9781493900916

      • Tapa blanda
      • Impresión bajo demanda

      Librería: Brook Bookstore On Demand, Napoli, NA, ItaliaBrook Bookstore On Demand

      Vendedor de 5 estrellas
      Contactar con el vendedor

      Condición: Nuevo

      EUR 270,34

      Envío por EUR 5,50 
      Se envía de Italia a Estados Unidos de America

      Cantidad disponible: Más de 20 disponibles

      Condición: new. Questo è un articolo print on demand.

    • Idioma: Inglés

      Editorial: Springer New York, 2014

      1493900919 / 9781493900916

      • Tapa blanda
      • Impresión bajo demanda

      Librería: moluna, Greven, Alemaniamoluna

      Vendedor de 5 estrellas
      Contactar con el vendedor

      Condición: Nuevo

      EUR 294,19

      Envío por EUR 48,99 
      Se envía de Alemania a Estados Unidos de America

      Cantidad disponible: Más de 20 disponibles

      Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Discuss the latest developments in the realm of drug safety, and expands its coverage of clinical trials considerably Provides a conceptual introduction to statistics and illustrates its important role in the new drug development process Adopts a conceptual.

    • Idioma: Inglés

      Editorial: Springer, Humana Okt 2014, 2014

      1493900919 / 9781493900916

      • Tapa blanda
      • Impresión bajo demanda

      Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemaniabuchversandmimpf2000

      Vendedor de 5 estrellas
      Contactar con el vendedor

      Condición: Nuevo

      EUR 353,09

      Envío por EUR 60,00 
      Se envía de Alemania a Estados Unidos de America

      Cantidad disponible: 1 disponibles

      Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -New Drug Development: Second Edition provides an overview of the design concepts and statistical practices involved in therapeutic drug development. This wide spectrum of activities begins with identifying a potentially useful drug candidate that can perhaps be used in the treatment or prevention of a condition of clinical concern, and ends with marketing approval being granted by one or more regulatory agencies. In between, it includes drug molecule optimization, nonclinical and clinical evaluations of the drug¿s safety and efficacy profiles, and manufacturing considerations. The more inclusive term lifecycle drug development can be used to encompass the postmarketing surveillance that is conducted all the time that a drug is on the market and being prescribed to patients with the relevant clinical condition. Information gathered during this time can be used to modify the drug (for example, dose prescribed, formulation, and mode of administration) in terms of its safety and its effectiveness. The central focus of the first edition of this book is captured by its subtitle, 'Design, Methodology, and Analysis'. Optimum quality study design and experimental research methodology must be employed if the data collected¿numerical representations of biological information¿are to be of optimum quality. Optimum quality data facilitate optimum quality statistical analysis and interpretation of the results obtained, which in turn permit optimum quality decisions to be made: Rational decision making is predicated on appropriate research questions and optimum quality numerical information. The book took a non-computational approach to statistics, presenting instead a conceptual framework and providing readers with a sound working knowledge of the importance of design, methodology, and analysis. Not everyone needs to be an expert in statistical analysis, but it is very helpful for work (or aspire to work) in the pharmaceutical and biologics industries to be aware of the fundamental importance of a sound scientific and clinical approach to the planning, conduct, and analysis of clinical trials.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 284 pp. Englisch.